Clinical trial · Interventional
Efficacy Study of Robotic Surgery for Rectal Cancer
Clinical Assessment of Laparoscopic and Robotic Surgery for Rectal Cancer - Randomized Phase II Trial
NCT01591798CI-TRIAL-00006858unknownPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
After introducing minimally invasive surgery, robotic surgery has been increasingly used in colorectal cancer. However, there is a few prospective study for robotic surgery. The aim of this trial is to evaluate the effectiveness and safety of robotic surgery in mid or low rectal cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Rectal Neoplasm | Rectal Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Laparoscopic surgery | Procedure | — | UNRESOLVED |
| Robotic surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Robotic surgery
- description
- Proctectomy using robot
- interventionNames
- Procedure: Robotic surgery
- type
- ACTIVE_COMPARATOR
- label
- Laparoscopic surgery
- description
- Conventional laparoscopic rectal resection
- interventionNames
- Procedure: Laparoscopic surgery
Primary outcomes (1)
- measure
- Quality of mesorectal excision
- timeFrame
- 7days after surgery (Pathologic report)
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * mid or low rectal cancer (within 9cm from anal verge) * pathologically proven as adenocarcinoma * written informed consent * no severe functional disability in lung and heart Exclusion Criteria: * invading adjacent organ * distant metastasis (lung, liver, brain, bone, distant lymph nodes etc.) * lateral pelvic lymph node metastasis * Have severe concomitant disease that might limit compliance or completion of the protocol. * Have any other malignancy that might impact 5-year survival or might be potentially confused with rectal cancer. * If female, be pregnant or breast feeding. * Hereditary colorectal cancer (HNPCC, FAP etc) * emergency operation
References
Publications (0)
Data not yet available
No reference posted for this study.